Product Information

BROMSITE 0.075% EYE DROPS is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $49.5483 per ML under NDC 49708075441. Its NADAC has been published 492 times since Feb 22, 2017.

FDA first approved this application on Apr 8, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the bromfenac market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BROMSITE 0.075% EYE DROPS

bromfenac
$49.5483per ML
High Outlier

Strength

.76 mg/mL

NDC

49708075441

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

BROMFENAC SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA206911

FDA Approved

4/8/2016

TE Code

AB

On Market Since

5/1/2016

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for BROMSITE 0.075% EYE DROPS has been published 492 times since Feb 22, 2017, and over the history we have for it it has risen 9.8%. The table below summarizes its recorded NADAC range and movement.

Current price$49.5483 per ML
All-time high$49.8920 (Nov 13, 2019)
All-time low$45.1387 (Feb 22, 2017)
52-week high$49.7699
52-week low$49.5434
Median price$49.6749
Average price$49.3533
Largest weekly change+8.0% (Feb 7, 2018)
Weeks tracked492
Tracking sinceFeb 22, 2017

Price History

1W

+0.0%

1M

+0.0%

3M

-0.1%

6M

-0.1%

1Y

-0.2%

3Y

-0.3%

5Y

-0.2%

All

+9.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BROMSITE 0.075% EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for BROMSITE 0.075% EYE DROPS, manufactured by Sun Pharmaceutical Industries Inc., is $49.5483 per ML (NDC 49708075441), effective Aug 19, 2026.

How has the price of BROMSITE 0.075% EYE DROPS changed over time?

Over the history we have for it, the NADAC for BROMSITE 0.075% EYE DROPS has risen 9.8%. It has been tracked across 492 weekly CMS publications since Feb 22, 2017.

What are the highest and lowest recorded NADAC prices for BROMSITE 0.075% EYE DROPS?

Since Feb 22, 2017, the NADAC for BROMSITE 0.075% EYE DROPS has ranged from a low of $45.1387 (Feb 22, 2017) to a high of $49.8920 (Nov 13, 2019), with a median of $49.6749 per ML.

Are there cheaper alternatives to BROMSITE 0.075% EYE DROPS?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BROMFENAC SOD 0.075% EYE DROP, is $24.0979 per ML — about 51% below BROMSITE 0.075% EYE DROPS.

Who manufactures BROMSITE 0.075% EYE DROPS?

BROMSITE 0.075% EYE DROPS (NDC 49708075441) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.